Clearside Biomedical, Inc.
Company files for Chapter 11 bankruptcy protection.
1 source·29/12, 11:16·sec.gov
Company delisted from Nasdaq, filed for bankruptcy.
1 source·08/12, 21:34·sec.gov
Clearside Biomedical files for Chapter 11 bankruptcy.
1 source·25/11, 21:08·sec.gov
10-Q form submitted!
1 source·14/11, 21:17·sec.gov
Company regained compliance with Nasdaq listing rules.
1 source·07/10, 20:12·sec.gov
Company announces a 1-for-15 reverse stock split.
2 sources·11/09, 11:26·sec.gov
Clearside amends agreements, receives additional funding.
1 source·08/09, 11:18·sec.gov
Company faces potential delisting from Nasdaq.
1 source·03/09, 20:32·sec.gov
Company faces delisting and proposes reverse stock split.
1 source·14/08, 20:14·sec.gov
10-Q form submitted!
1 source·08/08, 20:09·sec.gov
Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum
·finviz.com·21/05, 11:08
Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update
·finviz.com·14/05, 20:14
Clearside Biomedical Inc (CLSD) Q1 2025 Earnings Report Preview: What To Expect
·yahoo.com·13/05, 13:56